Clients
R&D-based Pharma
|
- Abbott
- Actelion
- ALK- ABELLO
- AstraZeneca
- Bayer Pharma
- BMS
- Boehringer Ingelheim
- Chiesi
- Daiichi-Sankyo
- Esteve
- Eisaï
- Ethypharm
- GSK
- HRA Pharma
- Ipsen
- Innothera
- J&J
- LFB
- Lundbeck
- Merck-Serono
- MSD
- Mundipharma
|
- Negma
-
Novartis
-
Novo-Nordisk
-
Nycomed-Altana
- Organon
- Pfizer
- Pierre Fabre
- Reckitt-Benckiser
- Roche
- Sanofi-Aventis
- Schering-Plough
- Schwabe
- Servier
- Shire
- Solvay-Fournier
- Takeda
- Thérabel
- Theramex
- UCB-Schwarz Pharma
- Urgo
- Wyeth
|
|
Biotechnologies – Vaccines
|
- Alexion
- Amgen
- Biogen-Idec
|
- Celgene
- Gilead
- GSK Biologicals
|
Generics
|
- Biogaran (Servier)
- Sandoz (Novartis)
- Stada (EG Labo)
|
- Teva
- Winthrop (Sanofi-Aventis)
- Wockhardt
|
Distributors
|
- Alliance Healthcare
- Alrhéas
- Collectif des groupements
- Pharma Référence
|
Banks – Investors
|
|
|
- PAI
- Sagard
- Weinberg Capital Partners
|
|
